Dr. Daniel Amen shared his BRIGHTMINDS approach for preventing Alzheimer's, addressing 11 risk factors including blood flow, ...

Alzheimer’s disease continues to rise as one of the most pressing health challenges facing aging populations today. It ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA ...

Donanemab was approved by the FDA in July 2024 to treat adults with early symptomatic Alzheimer's disease with confirmed ...

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

People in early stages of the disease may show other signs of cognitive deterioration such as being unable to follow ...

UCLA Health researchers mapped four distinct pathways leading to Alzheimer’s disease using electronic health records.   The ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

It's been recognized for some time that Alzheimer's disease affects brain regions differently and that tau - a protein known ...

Using brain gene expression maps from the Allen Human Brain Atlas, the researchers tested the degree to which Alzheimer’s risk genes explain the patterns of both actual and residual tau. This allowed ...